RIPA-56

CAS : 1956370-21-0

Ref. 3D-GDD37021

Informations sur le produit

• Nom: RIPA-56
• Marque: Biosynth
• Description: RIPA-56 is an experimental drug that belongs to a class of acyltransferases. It has shown to be effective in preventing the development of tubulointerstitial injury in the experimental model and prevents cytosolic calcium overload by inhibiting phospholipase A2. RIPA-56 also inhibits apoptosis pathways and has been shown to be effective against autoimmune diseases, such as hepatitis B virus-induced hepatic steatosis and toxic epidermal necrolysis. RIPA-56 interacts with toll-like receptor 4 (TLR4) which is a protein that recognizes bacterial lipopolysaccharides on the surface of cells and activates immune response.

Propriétés chimiques

• Masse moléculaire: 221.3 g/mol
• Formule: C₁₃H₁₉NO₂
• Degré de pureté: Min. 95%